Filter Results:
(791)
Show Results For
- All HBS Web
(791)
- People (1)
- News (108)
- Research (537)
- Events (1)
- Multimedia (7)
- Faculty Publications (304)
Show Results For
- All HBS Web
(791)
- People (1)
- News (108)
- Research (537)
- Events (1)
- Multimedia (7)
- Faculty Publications (304)
- April 2014 (Revised July 2015)
- Case
Sanofi Pasteur: The Dengue Vaccine Dilemma
By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
- Program
Growing as a Purposeful Leader
corporate purpose in every action they take Unleash "human magic"—and business results—through purposeful leadership Shape an environment that can allow every employee to be the biggest, best version of themselves and drive exceptional View Details
- Web
Key Concepts - Institute For Strategy And Competitiveness
Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Key Concepts Value-based health care is one of the most important... View Details
- January 2018
- Article
The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial
By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp
Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details
Keywords: Affordable Care Act (ACA); Subsidies; Weight Loss; Obesity; Incentives; Behavioral Economics; Motivation and Incentives; Behavior; Health Disorders; Health Care and Treatment; Compensation and Benefits; United States
John, Leslie K., Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein, and Kevin Volpp. "The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial." American Journal of Health Promotion 32, no. 1 (January 2018): 170–176.
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- 16 Dec 2014
- First Look
First Look: December 16
opposed to increased levels of funding from the governments. Analyses of 2011 and 2012 state pension reforms confirm that states opposed to accounting reform are more likely to cut pension benefits. Download working paper: http://ssrn.com/abstract=2533492 How Should We... View Details
Keywords: Sean Silverthorne
- 13 Mar 2023
- Research & Ideas
The Power of Personal Connections: How Shared Experiences Boost Performance
percentage points higher in patient satisfaction surveys than specialists with whom the primary care doctor didn’t train, finds new research published in JAMA Internal Medicine. PCPs and specialists who spent their early years together tended to show improved View Details
- 17 May 2016
- First Look
May 17, 2016
2016 New York: Oxford University Press Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business By: John A. Quelch. Abstract—The public health footprint associated with corporate behavior has come under... View Details
Keywords: Sean Silverthorne
- Program
PLD Module 5
strategic decisions with a deeper understanding of the financial implications Help your company deliver greater value to a wide range of stakeholders Navigate high-stakes negotiations and drive better outcomes Expand your personal and... View Details
- 30 Mar 2010
- First Look
First Look: March 30
outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer... View Details
Keywords: Sean Silverthorne
- 27 Sep 2013
- Working Paper Summaries
The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance
- 30 Jul 2013
- First Look
First Look: July 30
Publications 2013 pub Rx: Human Nature: How Behavioral Economics Is Promoting Better Health Around the World By: Ashraf, Nava Abstract—Why doesn't a woman who continues to have unwanted pregnancies avail herself of the free contraception... View Details
Keywords: Anna Secino
- Web
Publications - Institute For Strategy And Competitiveness
Outcomes Health Care Measurements that Improve Patient Outcomes by Robert S. Kaplan, PhD, MS, Lara Jehi, MD, MHCDS, Clifford Y. Ko, MD, MS, MSHS, FACS, FASCRS, Andrea Pusic,... View Details
- 02 Apr 2024
- What Do You Think?
What's Enough to Make Us Happy?
(Image created with Midjourney, an artificial intelligence tool) Happiness, an elusive condition we all want to experience, is a popular topic. It’s a complex subject. It may or may not require everything from good health to sufficient... View Details
Keywords: by James Heskett
- July 2021
- Article
Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time
By: Sam Ransbotham, Eric Overby and Michael C. Jernigan
Information systems generate copious trace data about what individuals do and when they do it. Trace data may affect the resolution of lawsuits by, for example, changing the time needed for legal discovery. Trace data might speed resolution by clarifying what events... View Details
Keywords: Analytics and Data Science; Lawsuits and Litigation; Digital Transformation; Welfare; Health Industry
Ransbotham, Sam, Eric Overby, and Michael C. Jernigan. "Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time." Management Science 67, no. 7 (July 2021): 4341–4361.
- Web
Research Areas - Doctoral
international ventures; the environments in which entrepreneurs make decisions; and social entrepreneurship. 4. Performance Measurement and Outcomes scholars study drivers and effectiveness of performance measurement and management... View Details
- July 2019
- Article
The Impact of Price Regulation on the Availability of New Drugs in Germany
By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
- 2017
- Article
Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals
By: Joshua W. Buckholtz, Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan and Arielle Baskin-Sommers
Antisocial behavior is often assumed to reflect aberrant risk processing. However, many of the most significant forms of antisocial behavior, including crime, reflect the outcomes of decisions made under conditions of ambiguity rather than risk. While risk and... View Details
Keywords: Ambiguity; Neuroscience; Neuroeconomics; Choice; Psychology; Decision Choice And Uncertainty; Behavior; Decision Choices and Conditions; Cost vs Benefits; Health Disorders
Buckholtz, Joshua W., Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan, and Arielle Baskin-Sommers. "Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals." Art. 2030. Scientific Reports 7 (2017).
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
their ability to serve the complex and interrelated needs of each patient over the full cycle of care. The greatest improvements in health care outcomes and efficiency will come from sustained, team-based... View Details